Wang Yin-Hu, Yang Wei, Yang Jing-Bo, Jia Yan-Jie, Tang Wei, Gershwin M Eric, Ridgway William M, Lian Zhe-Xiong
Liver Immunology Laboratory, Institute of Immunology and The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, China.
Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA 95616, USA.
J Autoimmun. 2015 May;59:26-37. doi: 10.1016/j.jaut.2015.01.011. Epub 2015 Feb 17.
CD4(+)Foxp3(+) regulatory T cells (Tregs) play a non-redundant role in control of excessive immune responses, and defects in Tregs have been shown both in patients and murine models of primary biliary cirrhosis (PBC), a progressive autoimmune biliary disease. Herein, we took advantage of a murine model of PBC, the dominant negative transforming growth factor β receptor II (dnTGFβRII) mice, to assess Treg genetic defects and their functional effects in PBC. By using high-resolution microarrays with verification by PCR and protein expression, we found profound and wide-ranging differences between dnTGFβRII and normal, wild type Tregs. Critical transcription factors were down-regulated including Eos, Ahr, Klf2, Foxp1 in dnTGFβRII Tregs. Functionally, dnTGFβRII Tregs expressed an activated, pro-inflammatory phenotype with upregulation of Ccl5, Granzyme B and IFN-γ. Genetic pathway analysis suggested that the primary effect of loss of TGFβ pathway signaling was to down regulate immune regulatory processes, with a secondary upregulation of inflammatory processes. These findings provide new insights into T regulatory genetic defects; aberrations of the identified genes or genetic pathways should be investigated in human PBC Tregs. This approach which takes advantage of biologic pathway analysis illustrates the ability to identify genes/pathways that are affected both independently and dependent on abnormalities in TGFβ signaling. Such approaches will become increasingly useful in human autoimmunity.
CD4(+)Foxp3(+)调节性T细胞(Tregs)在控制过度免疫反应中发挥着不可替代的作用,并且在原发性胆汁性肝硬化(PBC,一种进行性自身免疫性胆汁疾病)的患者和小鼠模型中均已显示出Tregs存在缺陷。在此,我们利用PBC小鼠模型,即显性负性转化生长因子β受体II(dnTGFβRII)小鼠,来评估Treg基因缺陷及其在PBC中的功能影响。通过使用高分辨率微阵列并经PCR和蛋白质表达验证,我们发现dnTGFβRII Tregs与正常野生型Tregs之间存在深刻且广泛的差异。dnTGFβRII Tregs中关键转录因子包括Eos、Ahr、Klf2、Foxp1均下调。在功能上,dnTGFβRII Tregs表现出一种活化的促炎表型,Ccl5、颗粒酶B和IFN-γ上调。基因通路分析表明,TGFβ通路信号缺失的主要影响是下调免疫调节过程,其次是炎症过程的上调。这些发现为T调节基因缺陷提供了新的见解;应在人类PBC Tregs中研究已鉴定基因或基因通路的异常情况。这种利用生物通路分析的方法说明了识别独立或依赖于TGFβ信号异常而受影响的基因/通路的能力。此类方法在人类自身免疫中将变得越来越有用。